Newswise Feature Channel: Diabetes

People From Some Racial and Ethnic Groups May Face Barriers to Obtaining Obesity Medications

University of California, Los Angeles (UCLA), Health Sciences — Wed, 18 Dec 2024 09:00:51 EST

Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites. The differences could not be fully explained by income or education level, health insurance coverage or clinical need.

Improving Health in Rural Areas Takes Community

University of Georgia — Thu, 12 Dec 2024 10:10:23 EST

Involving local leaders and churches could make all the difference in rural communities in diabetes prevention, according to a recent study from the University of Georgia.

Team Led by Columbia Engineering and Columbia University Irving Medical Center Wins ARPA-H Award for Up to $41M

Columbia University School of Engineering and Applied Science — Wed, 11 Dec 2024 13:05:13 EST

A multidisciplinary team led by Ken Shepard, a pioneering researcher in bioelectronics at Columbia Engineering, has won an award of up to $41 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a wireless bioelectronic device to treat obesity and diabetes. The team was selected by ARPA-H's Resilient Extended Automatic Cell Therapies (REACT) program to create bioelectronic devices that enable people to administer treatments of biologic drugs without the need for injections. Instead, engineered cells act as cell factories to produce the drugs, negating the need for the chemical modifications required to make such biologics shelf-stable, which often results in reduced efficacy.

Mount Sinai Researchers Move Closer to a Cure for Diabetes

Mount Sinai Health System — Wed, 11 Dec 2024 10:30:50 EST

Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new understanding of how human beta cell regenerative drugs work.

Lurie Children's Diabetes Program Receives 2024 T1D Exchange Outstanding Pediatric Team Award

Ann and Robert H. Lurie Children's Hospital of Chicago — Tue, 10 Dec 2024 12:00:34 EST

In November, Lurie Children's and Northwestern University co-hosted the 2024 T1D Exchange Learning Session in Chicago. The T1D Exchange Quality Improvement Collaborative (QIC) brings together clinics across the United States, connecting experts that collectively treat over 100,000 individuals with Type 1 diabetes.

New Targets for Diabetic Kidney Disease Could Prevent End Stage Kidney Failure

University of Bristol — Tue, 10 Dec 2024 06:25:28 EST

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug therapies preventing the disease's progression into end stage kidney failure.

Precision Diabetes Management: Glucose-Triggered Insulin Delivery Membrane

Chinese Academy of Sciences — Mon, 09 Dec 2024 08:20:18 EST

Scientists have developed an innovative glucose-responsive membrane capable of self-regulating insulin release, offering a potential revolution in diabetes management. This cutting-edge material responds to glucose levels by contracting, functioning as an automatic chemical valve that controls insulin delivery.

Ohio State to Study Approaches to Managing Blood Pressure After Pregnancy

Ohio State University Wexner Medical Center — Thu, 05 Dec 2024 12:00:55 EST

A research team from The Ohio State University Wexner Medical Center and College of Medicine will study approaches to postpartum blood pressure control among Ohio patients, as part of a $12.5 million three-state study.

Killing Two Birds with One Stone

Universite de Montreal — Tue, 03 Dec 2024 12:00:01 EST

An affordable and effective nutritional approach to help reduce inflammation and prevent Type 2 diabetes.

Breakthrough Obesity Treatment: A Micro Cure for a Big Problem

University of South Australia — Sun, 01 Dec 2024 22:10:29 EST

University of South Australia researchers have created a new, food-grade, natural solution for obesity, that not only cuts the kilos and improves metabolic health but does so without the nasty side effects.

No 'One Size Fits All' Treatment for Type 1 Diabetes, Study Finds

University of Bristol — Wed, 27 Nov 2024 09:00:00 EST

Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study has found.

Common Diabetes Drug Shows Promise for Reducing Harmful Alcohol Use

Research Society on Alcoholism — Tue, 26 Nov 2024 10:00:00 EST

An early-stage study has found that a drug commonly prescribed for diabetes may prove to help treat people with alcohol use disorder. The study, published in Alcohol: Clinical and Experimental Research, found that the diabetes drug metformin reduced alcohol intake in mice.

Diabetes Drug Appears to Fight Lung Cancer -- But Only in Overweight or Obese Patients

Roswell Park Comprehensive Cancer Center — Tue, 26 Nov 2024 08:00:50 EST

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.

Independent Evaluation Recognizes Ochsner Digital Medicine for Superior Hypertension Management

Ochsner Health — Mon, 25 Nov 2024 14:50:44 EST

A new independent report reveals that medication management solutions like Ochsner Digital Medicine deliver superior hypertension outcomes and long-term cost savings compared to other digital approaches

New Therapy From UI Health Offers FDA-Approved Treatment Option for Brittle Type 1 Diabetes

University of Illinois Chicago — Mon, 25 Nov 2024 12:25:39 EST

Lantidra is the only treatment currently approved by the U.S. Food and Drug Administration for the treatment of brittle type 1 diabetes.

Study Aims to Boost Diabetes Device Use Among Latinx Youth

Children's Hospital Los Angeles — Mon, 25 Nov 2024 11:20:56 EST

Jennifer Raymond, MD, MCR, Chief of the Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles, is co-leading an innovative multicenter study funded by a four-year R01 NIH grant testing a virtual peer group model--co-designed with youth and families--to increase diabetes technology use among Latinx adolescents.

Large Study of Diverse US Veterans Adds to Evidence that Moderate Drinking Does Not Protect Against Heart Disease or Diabetes

Research Society on Alcoholism — Sun, 24 Nov 2024 10:00:00 EST

Moderate alcohol use does not reduce cardiometabolic disease risk among veterans of European, African, or Hispanic ancestry, a new study suggests. The findings add to growing evidence that traditional research methods applied to drinking levels and certain disease outcomes have created illusory and misleading results. Heavy drinking is known to be linked to coronary heart disease (CHD) and type 2 diabetes (T2D). Traditional observational studies have, however, associated moderate drinking with the lowest risk and abstinence with a moderate risk (the U-curve or J-curve effect). In recent years, the U-curve has been increasingly attributed to confounding errors--when study results are distorted by other factors. In this case, the abstinence category is implicated since it establishes a false equivalence between study participants with widely differing risk factors (lifelong non-drinkers, those who stopped drinking for health or other alcohol-related problems, and those who falsely reporte

How to Avoid Adding Holiday Pounds

Hackensack Meridian Health — Thu, 21 Nov 2024 17:00:06 EST

We're faced with it every holiday season: delectable treats we "can't resist" for one reason or another, thus we overindulge. And for those dealing with diabetes or high blood pressure, the holidays can be especially challenging. A Hackensack Meridian Health expert has some tips on how to enjoy and keep healthy.

Neuro-ophthalmologist with Texas Tech Physicians of El Paso Available to Speak on Diabetic Eye Disease

Texas Tech University Health Sciences Center El Paso — Thu, 21 Nov 2024 13:45:33 EST

Universite de Montreal: Vincent Poitout, next Vice-Rector of Research

Universite de Montreal — Thu, 21 Nov 2024 12:00:53 EST

The University Council appointed Vincent Poitout to succeed Marie-Josee Hebert as Vice-Rector of Research, Discovery, Creation and Innovation.